2022. A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital. Asian Journal of Pharmaceutical and Health Sciences. 12, 4 (Dec. 2022), 2729–2738. DOI:https://doi.org/10.5530/ezagjy22.